quest report revenu street estim adjust ep
street upsid driven increment volum
recent ad in-network busi prefer lab network impact visibl
low releas detail expect june anticip could
modest multi-year volum driver manag left full year guidanc unchang
increment rais estim price base
unchang ep estim
result quest report revenu increas street rev/
req better street organ test volum growth
street driven network lab adjust
posit weather effect bpt one fewer day bpt underli organ
volum growth adjust oper margin street
bp qoq declin due one less sell day reimburs pressur higher patient
concess adjust ep street
busi updat quest two seven lab includ prefer
lab network manag updat guidanc award detail yet
releas assum contribut volum sever
year due like chang benefit design take time manag remain
optimist delay pama data collection/releas continu pursu
legal legisl option continu assum expand definit
applic lab yield flattish slight posit pama adjust importantli
manag clarifi sever headwind drug abus vitamin
hcv larg clear
guidanc quest left guidanc unchang revenu street
adjust ep greater street cash flow oper
street capital-expenditure manag note organ
volum increas cours quarter releas unitedhealth
prefer lab network releas move high end guidanc
stock believ pln win could modest multi-
year growth driver although expect could take pronounc
impact henc remain neutral share manag understand upbeat
call believ share could ralli network launch juli
risk includ weak volum competit margin reimburs pressur
largest independ clinic lab world
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
us million except note
servic
servic
compani report piper jaffray co current disclosur inform compani locat
